Most Clicked StoriesMore >


Study compares outcomes for GLP-1 receptor agonists in diabetes

DiabetesPro SmartBrief | Feb 16, 2017

Type 2 diabetes patients on dulaglutide had higher adherence and lower discontinuation than those on exenatide or liraglutide, according to a study in Diabetes, Obesity and Metabolism. Researchers found that dulaglutide use was also associated with higher mean days on treatment and a higher number of patients who achieved a proportion of days covered. Physician's Briefing/HealthDay News (02/15)


Study: Liraglutide may block benefits of exercise in dysregulated diabetes

DiabetesPro SmartBrief | Feb 17, 2017

Abdominal adiposity tied to diabetes, cardiometabolic risks, study finds

DiabetesPro SmartBrief | Feb 15, 2017

Researchers ID biomarker of microalbuminuria in diabetes

DiabetesPro SmartBrief | Feb 14, 2017

Health benefits seen in periodic fasting diet, study finds

DiabetesPro SmartBrief | Feb 17, 2017

Researchers examine effect of lixisenatide on older type 2 diabetes patients

DiabetesPro SmartBrief | Feb 16, 2017

Download the new 2017 Standards of Care app

DiabetesPro SmartBrief | Feb 17, 2017

Report: Exercise affects glucose control in type 1 diabetes

DiabetesPro SmartBrief | Feb 14, 2017

Study links insulin resistance to circulating extracellular RNAs

DiabetesPro SmartBrief | Feb 15, 2017

Study compares metabolic response to plant, animal protein diets in diabetes

DiabetesPro SmartBrief | Feb 14, 2017


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


Free kit for children newly diagnosed with type 1 diabetes

DiabetesPro SmartBrief | Feb 20, 2017

Download the new 2017 Standards of Care app

DiabetesPro SmartBrief | Feb 17, 2017

Apply for core research funding opportunities

DiabetesPro SmartBrief | Feb 17, 2017

ADA launches online hub for insulin affordability advocates

DiabetesPro SmartBrief | Feb 16, 2017

Apply today for the 4th annual Focus on Fellows program

DiabetesPro SmartBrief | Feb 14, 2017




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


Poll: Do you think a glucose-sensing contact lens would be of benefit to your patients?

Chart.